UFF
EXEL icon

USA Financial Formulas’s Exelixis EXEL Stock Holding History

USA Financial Formulas’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.3K Buy
1,054
+1,040
+7,429% +$50.6K 0.01% 254
2026
Q1 		$600 Hold
14
– – ﹤0.01% 372
2025
Q4 		$614 Buy
+14
New +$579 ﹤0.01% 349
2025
Q3 		– Sell
-6,773
Closed -$299K – 285
2025
Q2 		$299K Sell
6,773
-3,157
-32% -$126K 0.05% 101
2025
Q1 		$367K Buy
9,930
+8,962
+926% +$319K 0.06% 93
2024
Q4 		$32.2K Buy
+968
New +$31.4K 0.01% 246
2024
Q1 		– Sell
-2,060
Closed -$49.4K – 342
2023
Q4 		$49.4K Buy
2,060
+1,935
+1,548% +$42.1K 0.01% 198
2023
Q3 		$2.73K Buy
+125
New +$2.62K ﹤0.01% 308

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

USA Financial Formulas's EXEL Position: Q2 2026 in Review

USA Financial Formulas increased its Exelixis (EXEL) stake by 7,429% in Q2 2026, buying an estimated $50.6K and bringing the position to 1,054 shares worth $57.3K. The position accounts for 0.01% of the portfolio, ranked #254.

USA Financial Formulas first reported a position in EXEL in Q3 2023 and has held it in 8 quarters since. The position peaked at $367K in Q1 2025. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • USA Financial Formulas held 1,054 shares of Exelixis worth $57.3K as of Q2 2026.
  • USA Financial Formulas bought 1,040 Exelixis shares in Q2 2026, an estimated $50.6K.
  • Exelixis made up 0.01% of USA Financial Formulas's portfolio in Q2 2026, its #254 holding.
  • USA Financial Formulas first reported a position in Exelixis in Q3 2023 and has held it in 8 quarters since.
  • USA Financial Formulas's Exelixis position peaked at $367K in Q1 2025.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.